Benjamin Edwards Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.84M Buy
45,195
+26,690
+144% +$2.14M 0.03% 455
2025
Q4
$1.76M Buy
18,505
+79
+0.4% +$7.75K 0.02% 549
2025
Q3
$1.8M Buy
18,426
+670
+4% +$69.4K 0.02% 514
2025
Q2
$1.91M Buy
17,756
+1,958
+12% +$198K 0.02% 467
2025
Q1
$1.59M Buy
15,798
+815
+5% +$82.1K 0.02% 472
2024
Q4
$1.34M Buy
14,983
+829
+6% +$73K 0.02% 529
2024
Q3
$1.19M Buy
14,154
+13,880
+5,066% +$1.09M 0.02% 550
2024
Q2
$21K Buy
274
+93
+51% +$6.81K ﹤0.01% 583
2024
Q1
$12K Buy
+181
New +$11.6K ﹤0.01% 624

Other funds holding BSX

Benjamin Edwards Inc's BSX Position: Q1 2026 in Review

Benjamin Edwards Inc increased its Boston Scientific (BSX) stake by 144% in Q1 2026, buying an estimated $2.14M and bringing the position to 45,195 shares worth $2.84M. The position accounts for 0.03% of the portfolio, ranked #455.

Benjamin Edwards Inc first reported a position in BSX in Q1 2024 and has held it in 9 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Benjamin Edwards Inc held 45,195 shares of Boston Scientific worth $2.84M as of Q1 2026.
  • Benjamin Edwards Inc bought 26,690 Boston Scientific shares in Q1 2026, an estimated $2.14M.
  • Boston Scientific made up 0.03% of Benjamin Edwards Inc's portfolio in Q1 2026, its #455 holding.
  • Benjamin Edwards Inc first reported a position in Boston Scientific in Q1 2024 and has held it in 9 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Benjamin Edwards Inc's 13F filing for Q1 2026, filed 12 May 2026.